JP5788496B2 - 複素環化合物およびその用途 - Google Patents

複素環化合物およびその用途 Download PDF

Info

Publication number
JP5788496B2
JP5788496B2 JP2013506362A JP2013506362A JP5788496B2 JP 5788496 B2 JP5788496 B2 JP 5788496B2 JP 2013506362 A JP2013506362 A JP 2013506362A JP 2013506362 A JP2013506362 A JP 2013506362A JP 5788496 B2 JP5788496 B2 JP 5788496B2
Authority
JP
Japan
Prior art keywords
group
optionally substituted
ring
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013506362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535408A (ja
JP2013535408A5 (enExample
Inventor
正城 郡
郡　　正城
稔博 今枝
稔博 今枝
信二 中村
信二 中村
昌志 豊福
昌志 豊福
栄治 本多
栄治 本多
恭臣 浅野
恭臣 浅野
治 宇治川
治 宇治川
倫代 望月
倫代 望月
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to JP2013506362A priority Critical patent/JP5788496B2/ja
Publication of JP2013535408A publication Critical patent/JP2013535408A/ja
Publication of JP2013535408A5 publication Critical patent/JP2013535408A5/ja
Application granted granted Critical
Publication of JP5788496B2 publication Critical patent/JP5788496B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP2013506362A 2010-08-10 2011-08-09 複素環化合物およびその用途 Active JP5788496B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013506362A JP5788496B2 (ja) 2010-08-10 2011-08-09 複素環化合物およびその用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
JP2010179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof
JP2013506362A JP5788496B2 (ja) 2010-08-10 2011-08-09 複素環化合物およびその用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015149216A Division JP6113789B2 (ja) 2010-08-10 2015-07-29 複素環化合物およびその用途

Publications (3)

Publication Number Publication Date
JP2013535408A JP2013535408A (ja) 2013-09-12
JP2013535408A5 JP2013535408A5 (enExample) 2014-09-18
JP5788496B2 true JP5788496B2 (ja) 2015-09-30

Family

ID=44534564

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013506362A Active JP5788496B2 (ja) 2010-08-10 2011-08-09 複素環化合物およびその用途
JP2015149216A Active JP6113789B2 (ja) 2010-08-10 2015-07-29 複素環化合物およびその用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015149216A Active JP6113789B2 (ja) 2010-08-10 2015-07-29 複素環化合物およびその用途

Country Status (39)

Country Link
US (11) US8575154B2 (enExample)
EP (1) EP2603513B1 (enExample)
JP (2) JP5788496B2 (enExample)
KR (1) KR101852215B1 (enExample)
CN (2) CN104926837A (enExample)
AR (1) AR082618A1 (enExample)
AU (1) AU2011290126B2 (enExample)
BR (1) BR112013002250B1 (enExample)
CA (1) CA2807460C (enExample)
CL (1) CL2013000380A1 (enExample)
CO (1) CO6680700A2 (enExample)
CR (1) CR20130066A (enExample)
CY (1) CY1123507T1 (enExample)
DK (1) DK2603513T3 (enExample)
DO (1) DOP2013000030A (enExample)
EA (1) EA022078B1 (enExample)
EC (1) ECSP13012478A (enExample)
ES (1) ES2793723T3 (enExample)
GE (1) GEP20156216B (enExample)
HR (1) HRP20200844T1 (enExample)
HU (1) HUE049460T2 (enExample)
IL (1) IL224452A (enExample)
LT (1) LT2603513T (enExample)
MA (1) MA34509B1 (enExample)
MX (1) MX349470B (enExample)
MY (1) MY165908A (enExample)
NZ (1) NZ607593A (enExample)
PE (1) PE20131116A1 (enExample)
PH (1) PH12013500247A1 (enExample)
PL (1) PL2603513T3 (enExample)
PT (1) PT2603513T (enExample)
RS (1) RS60311B1 (enExample)
SG (1) SG187656A1 (enExample)
SI (1) SI2603513T1 (enExample)
TW (1) TWI504604B (enExample)
UA (1) UA111594C2 (enExample)
UY (1) UY33551A (enExample)
WO (1) WO2012020848A1 (enExample)
ZA (1) ZA201301120B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013118845A1 (ja) * 2012-02-08 2015-05-11 武田薬品工業株式会社 複素環化合物およびその用途
JP2016006080A (ja) * 2010-08-10 2016-01-14 武田薬品工業株式会社 複素環化合物およびその用途

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5976011B2 (ja) * 2011-04-05 2016-08-23 武田薬品工業株式会社 スルホンアミド誘導体およびその用途
CA2915405A1 (en) * 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
CA2916653C (en) 2013-06-27 2017-07-18 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
MX2016007259A (es) 2013-12-03 2016-08-04 Du Pont Pirrolidinonas como herbicidas.
AU2015284280C1 (en) 2014-07-02 2020-02-13 Fmc Corporation Piperidinone herbicides
JP6611816B2 (ja) 2014-12-08 2019-11-27 エフ エム シー コーポレーション ３−オキソ−３−（アリールアミノ）プロパノエイト、その製造方法、およびピロリジノンの製造におけるその使用
JP6956637B2 (ja) 2015-04-10 2021-11-02 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 除草剤としての置換環状アミド
CN107531658B (zh) 2015-04-27 2021-07-27 Fmc公司 作为除草剂的丁内酯
ES2865330T3 (es) * 2015-04-29 2021-10-15 Janssen Pharmaceutica Nv Azabenzimidazoles y su uso como moduladores del receptor AMPA
JP6800885B2 (ja) * 2015-04-29 2020-12-16 ヤンセン ファーマシューティカ エヌ．ベー． イミダゾピラジン及びピラゾロピリミジン、並びにａｍｐａ受容体調節物質としてのこれらの使用
AU2016259529B2 (en) 2015-05-12 2020-10-01 Fmc Corporation Aryl substituted bicyclic compounds as herbicides
US10906873B2 (en) 2015-05-29 2021-02-02 Fmc Corporation Substituted cyclic amides as herbicides
JP6949730B2 (ja) 2015-06-02 2021-10-13 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 置換環状アミドおよび除草剤としてのそれらの使用
CN108137512B (zh) 2015-07-31 2022-05-31 Fmc公司 用作除草剂的环状n-酰胺化合物
PL3331892T3 (pl) * 2015-08-06 2019-11-29 Hoffmann La Roche Sposób wytwarzania pochodnych kwasu GalNAc
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
ES2958741T3 (es) 2016-12-21 2024-02-14 Fmc Corp Herbicidas de nitrona
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用，药物组合物
AU2018239940B2 (en) 2017-03-21 2023-12-07 Fmc Corporation Herbicidal mixture, composition and method
SG11201908640TA (en) 2017-03-21 2019-10-30 Fmc Corp Pyrrolidinones and a process to prepare them
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
JP7250686B2 (ja) * 2017-10-06 2023-04-03 武田薬品工業株式会社 複素環化合物
US11447488B2 (en) 2017-10-06 2022-09-20 Takeda Pharmaceutical Company Limited Heterocyclic compounds
CR20220160A (es) 2019-09-16 2022-06-16 Takeda Pharmaceuticals Co Derivados de piridazin-3(2h)-ona fusionados con azol
WO2021229294A1 (en) * 2020-05-15 2021-11-18 Takeda Pharmaceutical Company Limited Treatment for depression
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025226591A1 (en) 2024-04-22 2025-10-30 Neurocrine Biosciences, Inc. Methods of administering 9-[4-(cyclohexyloxy)phenyl]-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide without side effects

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (enExample) 1986-10-22 1992-09-04
JPH0285851A (ja) 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) * 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) * 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
EP1229786A1 (en) 1999-11-04 2002-08-14 Colorado State University Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1275951C (zh) * 2001-10-10 2006-09-20 神经研究公司 新的苯并噻嗪衍生物、其制备和应用
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) * 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0713529A2 (pt) 2006-06-23 2012-04-17 Nufarm Australia Ltd composição herbicida de fenóxi alcanoato e método de preparação e uso
EA015600B1 (ru) * 2006-12-11 2011-10-31 Эли Лилли Энд Компани Агенты, усиливающие действие амра-рецепторов
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
WO2009061699A1 (en) 2007-11-05 2009-05-14 Schering Corporation Gamma secretase modulators
CA2709784A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
JPWO2009119088A1 (ja) 2008-03-25 2011-07-21 武田薬品工業株式会社 複素環化合物
JP2009248543A (ja) 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
AU2009313527A1 (en) * 2008-11-06 2010-05-14 Merck Sharp & Dohme Corp. Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
WO2011007756A1 (ja) 2009-07-13 2011-01-20 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
EA022078B1 (ru) * 2010-08-10 2015-10-30 Такеда Фармасьютикал Компани Лимитед Гетероциклическое соединение и его применение

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016006080A (ja) * 2010-08-10 2016-01-14 武田薬品工業株式会社 複素環化合物およびその用途
JPWO2013118845A1 (ja) * 2012-02-08 2015-05-11 武田薬品工業株式会社 複素環化合物およびその用途

Also Published As

Publication number Publication date
US20150353578A1 (en) 2015-12-10
US20180162875A1 (en) 2018-06-14
KR20130138738A (ko) 2013-12-19
CR20130066A (es) 2013-05-03
US20200317692A1 (en) 2020-10-08
AU2011290126B2 (en) 2016-01-07
BR112013002250B1 (pt) 2020-10-27
CN103180326A (zh) 2013-06-26
EA201390222A1 (ru) 2013-08-30
US9884875B2 (en) 2018-02-06
PT2603513T (pt) 2020-06-08
CA2807460A1 (en) 2012-02-16
US20140080817A1 (en) 2014-03-20
BR112013002250A2 (pt) 2016-05-24
MX2013001614A (es) 2013-07-05
ES2793723T3 (es) 2020-11-16
WO2012020848A8 (en) 2012-09-27
US20130190291A1 (en) 2013-07-25
US11279713B2 (en) 2022-03-22
UY33551A (es) 2012-03-30
CO6680700A2 (es) 2013-05-31
RS60311B1 (sr) 2020-07-31
ZA201301120B (en) 2014-04-30
EP2603513A1 (en) 2013-06-19
MA34509B1 (fr) 2013-09-02
CN103180326B (zh) 2015-06-10
IL224452A (en) 2017-11-30
US8916551B2 (en) 2014-12-23
US8575154B2 (en) 2013-11-05
JP2013535408A (ja) 2013-09-12
CY1123507T1 (el) 2022-03-24
TWI504604B (zh) 2015-10-21
JP2016006080A (ja) 2016-01-14
US20240360156A1 (en) 2024-10-31
AU2011290126A1 (en) 2013-03-07
PE20131116A1 (es) 2013-10-24
CA2807460C (en) 2018-09-18
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
US9499568B2 (en) 2016-11-22
US20130184266A1 (en) 2013-07-18
LT2603513T (lt) 2020-05-25
US20150073137A1 (en) 2015-03-12
JP6113789B2 (ja) 2017-04-12
US20170022222A1 (en) 2017-01-26
MY165908A (en) 2018-05-18
DK2603513T3 (da) 2020-06-15
US8778934B2 (en) 2014-07-15
GEP20156216B (en) 2015-01-12
US10654874B2 (en) 2020-05-19
HRP20200844T1 (hr) 2020-08-21
NZ607593A (en) 2015-01-30
US20190263832A1 (en) 2019-08-29
PL2603513T3 (pl) 2020-07-27
CL2013000380A1 (es) 2013-05-31
WO2012020848A1 (en) 2012-02-16
US9150591B2 (en) 2015-10-06
MX349470B (es) 2017-07-31
HUE049460T2 (hu) 2020-09-28
AR082618A1 (es) 2012-12-19
EA022078B1 (ru) 2015-10-30
DOP2013000030A (es) 2013-03-15
US20120077799A1 (en) 2012-03-29
EP2603513B1 (en) 2020-03-11
TW201217386A (en) 2012-05-01
CN104926837A (zh) 2015-09-23
PH12013500247A1 (en) 2013-03-11
SG187656A1 (en) 2013-03-28
KR101852215B1 (ko) 2018-04-25
ECSP13012478A (es) 2013-04-30

Similar Documents

Publication Publication Date Title
US20240360156A1 (en) Heterocyclic compound and use thereof
WO2011036889A1 (ja) 複素環化合物
JP6134654B2 (ja) 複素環化合物およびその用途
HK1182701B (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator
HK1182701A (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140729

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140729

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150414

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150612

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150630

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150729

R150 Certificate of patent or registration of utility model

Ref document number: 5788496

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250